Ošetřovatelské perspektivy 2022, 5(2):97-108 | DOI: 10.25142/osp.2022.009

THE NEGATIVE EFFECT OF PARKINSON'S DISEASE ON THE PATIENT'S PSYCHOLOGICAL AND SOCIAL WELL-BEING

Jana Lauková1, Mária Šupínová1, Zuzana Frčová2, Elena Janiczeková1, Denisa Ivaničová2, Júlia Jankovičová1
1 Katedra ošetrovateľstva, Fakulta zdravotníctva SZU so sídlom v Banskej Bystrici
2 Katedra fyzioterapie, Fakulta zdravotníctva SZU so sídlom v Banskej Bystrici

Background: It has been found that at least half of patients with a prediction of Parkin- son's disease may have severe non-motor symptoms during the course of the disease, the impact of which on quality of life is not solely due to motor difficulties.

Aim: The aim of the theses is to analyze the impact of non-motoric symptomatology on the Quality of Life by patient´s with Parkinson´s Disease.

Methods: Narrative review studyfrom databases PubMed, DOI, Scopus, Web of Science.

Results: Mood disorders, depression, anxiety, apathy, cognitive changes and somatic perception of pain are the most important predictive factors for the mental component   of quality of life. Expectations the patients have from their close social environment are more of an emotional nature such as communication, keeping in touch in times of dis- tress, but also economic distress. Non-motor symptoms are under-reported, as patients may not associate them with Parkinson's disease and can be a source of embarrassment and lower confidence, increasing their social isolation.
Discussion and conclusion: Studies confirm that persons with Parkinson's disease have to cope with physical discomfort, loss of social relationships, financial activities, work  and leisure time. The quality assessment also allows the evaluation of the treatment ef- fectiveness or acts as an indicator for the choice of the next possible treatment and nur- sing approach.

Keywords: Parkinson´s Disease, Qualita of Life, Non Motoric Syndrome, Narrative review study

Received: January 23, 2022; Revised: February 16, 2022; Accepted: February 16, 2022; Published: December 9, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lauková J, Šupínová M, Frčová Z, Janiczeková E, Ivaničová D, Jankovičová J. THE NEGATIVE EFFECT OF PARKINSON'S DISEASE ON THE PATIENT'S PSYCHOLOGICAL AND SOCIAL WELL-BEING. Ošetřovatelské perspektivy. 2022;5(2):97-108. doi: 10.25142/osp.2022.009.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. AARSLAND, D., PAHLHAGEN, S., BALLARD, C. G., EHRT, U. & SVENNINGSSON, P. 2011. Depression in Parkinson disease - epidemiology, mechanisms and management. Nat Rev Neurol. 2011, Dec 26, vol. 8, no. 1, p. 35-47. doi: 10.1038/nrneurol. Go to original source... Go to PubMed...
    2. ANANG, J. B., GAGNON, J. F., BERTRAND, J. A., ROMENETS, S. R., LATREILLE, V., PANISSET, M., MONTPLAISIR, J. & POSTUMA, R. B. Predictors of dementia in Parkinson disease: a prospective cohort study. Neurology. 2014, Sep 30, vol. 83, no. 14, p. 1253-60. doi: 10.1212/WNL.0000000000000842. Epub 2014; Aug; 29. PMID: 25171928; PMCID: PMC4180482. Go to original source... Go to PubMed...
    3. ARMSTRONG, M. J. & OKUN, M. S. Diagnosis and Treatment of Parkinson Disease: A Review. JAMA. 2020, Feb 11, vol. 323, no. 6, p. 548-560. doi: 10.1001/jama.2019.22360. Go to original source... Go to PubMed...
    4. BARICHELLA, M., CEREDA, E., CASSANI, E., PINELLI, G., IORIO, L., FERRI, V., PRIVITERA, G., PASQUA, M., VALENTINO, A., MONAJEMI, F., CARONNI, S., PUSANI, C., BOLLIRI, C., FAIERMAN, S. A., LUBISCO, A., FARZZITTTA, G., PETRONI, M. L. & PEZZOLI, G. Dietary habits and neurological features of Parkinson´s Disease pateints:Implication for pracice. Clin Nutr. 2017, Aug, vol. 36, no. 4, p. 1054-1061. doi:101016/j.clnu.2016.06.20. Epub 2016Jul 5. PMID:27406858. Go to original source... Go to PubMed...
    5. BEARD, J. D., STEEGE, A. L. & JU, J. et al. Mortality from Amyotrophic Lateral Sclerosis and Parkinson's Disease Among Different Occupation Groups - United States, 1985- 2011. MMWR Morbidity and Mortality Weekly. Report. 2017, vol. 66, no. 27, p. 718-22. Go to original source... Go to PubMed...
    6. BENETIN, J. Komorbidita pri Parkinsonovej chorobe. Neurol. prax. 2005, roč. 6, č. 5, s. 242-246.
    7. BENETIN, J. et al. Ako žiť s Parkinsonovou chorobou. Lundbeck: 2014, 2 vyd. ISBN 978-80-89434-23-7.
    8. BOSTANTJOPOULOU, S., KATSAROU, Z., DANGLIS, I., KARAKASIS, H., MILIONI, D. & FALUP-PECURARIU, C. Self-reported autonomic symptoms in Parkinson's disease: properties of the SCOPA-AUT scale. Hippokratia. 2016, Apr-Jun, vol. 20, no. 2, p. 115- 120. PMID: 28416907; PMCID: PMC5388511. Go to PubMed...
    9. BRUDEK, T. Inflammatory Bowel Diseases and Parkinson's Disease ts. J Parkinsons Dis. 2019, vol. 9, no. s2, p. S331-S344. doi: 10.3233/JPD-191729. Go to original source... Go to PubMed...
    10. BUDREWICZ, S., ZMARZŁY, A., RĄCZKA, D., SZCZEPAŃSKA, A., KOZIOROWSKA-GAWRON, E., SŁOTWIŃSKI, K. & KOSZEWICZ, M. Clinical and nutritional correlations in Parkinson's disease: Preliminary report. Adv Clin Exp Med. 2019, Feb, vol. 28, no. 2, p. 193-198. doi: 10.17219/acem/76375. PMID: 29963785. Go to original source... Go to PubMed...
    11. DARWEESH SIRVAN, K. L., RAPHAEL, K. G., BRUNDIN, P., MATTHEWS, H., WYSE, R. K., CHEN, H. & BLOEM, B. R. Parkinson Matters. J Parkinsons Dis. 2018, vol. 8, no. 4, p. 495-498. doi: 10.3233/JPD-181374. Go to original source... Go to PubMed...
    12. DORSEY, E. R., SHERER, T., OKUN, M. S., & BLOEM, B. R. J Parkinsons Dis . 2018; 8 (s1):S3-S8. doi: 10.3233/JPD-181474. The Emerging Evidence of the Parkinson Pandemic. Journal of Parkinson's disease. 2011. ISSN: 1877-7171 (Print), 1877-718X (Electronic). Go to original source... Go to PubMed...
    13. EPDA (European Parkinsons´s Disease Association). Prevalence of Parkinsons´s Disease. 2014. Dostupné na: <http://www.epda.eu.com/en/parkinsons/life-with--parkinsons/part- 1/ prevalence-of-parkinsons-disease/>.
    14. FAN, Y., LIANG, X., HAN, L., SHEN, Y., SHEN, B., CHEN, C., SUN, Y., WANG, J. & TANG, Y. Determinants of Quality of Life According to Cognitive Status in Parkinson's Disease. Front. Aging Neurosci. 2020, 12:269. doi: 10.3389/fnagi.2020.00269. Go to original source... Go to PubMed...
    15. FERESHTEHNEJAD, S. M., SHAFIEESABET, M., FARHADI, F., HADIZADEH, H., RAHMAN, A. & NADERI, N. et al. Heterogeneous determinants of quality of life in different phenotypes of parkinson's disease. PLoS One. 2015, 10:e0137081. doi: 10.1371/journal. pone.013708. Go to original source... Go to PubMed...
    16. GROFIK, M. et al. Parkinsonova choroba a domáca starostlivosť. In: Liečba Parkinsonovej choroby. SPS, 2021. s. 12-15. ISBN 978-80-570-2780-5.
    17. HELLY, M. A, MORIS JOHN, G. L., REID WAYNE, G. J. & TRAFFICANTE BAPPSCMATHS, R. Sydney multicenter study of Parkinson's disease: Non-L-dopa-responsive problems dominate at 15 years. Mov Dis. 2005. https://doi.org/10.1002/ mds.20324. Go to original source... Go to PubMed...
    18. HERNANDEZ, D. G., REED, X. & SINGLETON, A. B. Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance. J Neurochem. 2016, Oct, vol. 139, no. 1, 59-74. doi: 10.1111/jnc.13593. Go to original source... Go to PubMed...
    19. HINNELL, C., HURT, C. S., LANDAU, S., BROWN, R. G. & SAMUEL, M. Nonmotor versus motor symptoms: how much do they matter to health status in Parkinson's disease? Mov. Disord. 2012, vol. 27, p. 236-241. doi: 10.1002/mds.23961. Go to original source... Go to PubMed...
    20. JÄRVELÄ, J. T., RINNE, J. O., ESKOLA, O. & KAASINEN, V. Mortality in Parkinson's disease is not associated with the severity of early dopaminergic defect. Parkinsonism Relat Disord. 2014, vol. 20, no. 8, p. 894-97. Doi:10.1016/j.parkreldis.2014.05.010. Go to original source... Go to PubMed...
    21. KADASTIK-EERME, L., ROSENTHAL, M., PAJU, T., MULDMAA, M. & TABA, P. Health-related quality of life in Parkinson's disease: a cross-sectional study focusing on non- motor symptoms. Health Qual. Life Outcomes. 2015, 13:83. doi: 10.1186/s12955-015- 0281-x. Go to original source... Go to PubMed...
    22. KHALID, A. & HUW, R. M. Parkinson's disease: chameleons and mimics. Pract Neurol. 2015, Feb, vol. 15, no. 1, p. 14-25. doi: 10.1136. Go to original source... Go to PubMed...
    23. KIM, N., YUN, M., OH, Y. J. & CHOI, H. J. Mind-altering with the gut: Modulation of the gut-brain axis with probiotics. J Microbiol. 2018, Mar, vol. 56, no. 3, p. 172-182. doi: 10.1007/s12275-018-8032-4. Epub 2018 Feb 28. PMID: 29492874. Go to original source... Go to PubMed...
    24. KNIPE, M., WICKREMARATCHI, M. M., WYATT-HAINES, E., MORRIS, H. R., BEN- DULEEKA, M., KNIPE, W., WICKREMARATCHI, M. M., WYATT-HAINES, E., HUW, R. M. & SHLOMO, Y. B. Quality of life in young- compared with late-onset Parkinson's disease. Mov Disord. 2011, Sep, vol. 26, no. 11, p. 2011-8. doi: 10.1002/mds.23763. Go to original source... Go to PubMed...
    25. KUHLMAN, G. D, FLANIGAN, J. L., SPERLING, S. A. & BARRETT, M. J. Predictors of health-related quality of life in Parkinson's disease. Parkinsonism Relat Disord. 2019, 65, p. 86-90. doi: 10.1016/j.parkreldis.2019.05.009. Go to original source... Go to PubMed...
    26. LAWRENCE, B. J., GASSON, N., KANE, R., BUCKS, R. S. & LOFUS, A. M. Activities of Daily Living, Depression, and Quality of Life in Parkinson's Disease. PLoS ONE. 2014, vol. 9, no. 7, e102294. doi.org/10.1371/journal.pone.0102294. Go to original source... Go to PubMed...
    27. LAWSON, R. A., YARNALL, A. J., JOHNSTON, F., DUNCAN, G. W., KHOO, T. K., COLLERTON, D., TAYLOR, J. P. & BURN, D. J., ICICLE-PD STUDY GROUP. Cognitive impairment in Parkinson's disease: impact on quality of life of carers. J Geriatr Psychiatry. 2017, Dec, vol. 32, no. 12, p. 1362-1370. doi: 10.1002/gps.4623. Epub 2016 Dec 7. PMID: 27925292; PMCID: PMC5724657. Go to original source... Go to PubMed...
    28. LAWSON, R. A., YARNALL, A. J., DUNCAN, G. W., BREEN, D. P., KHOO, T. K., & WILLIAMS-GRAY, CH. et a l. Cognitive decline and quality of life in incident Parkinson's disease: the role of attention. Parkinsonism Relat. Disord. 2016, 27, 47-53. doi: 10.1016/j. parkreldis.2016.04.009. Go to original source... Go to PubMed...
    29. LUCAS-CARRASCO, R., PASCUAL-SEDANO, B., GALÁN, I., KULISEVSKY, J.,SASTRE-GARRIGA, J. & GÓMEZ-BENITO, J. The WHOQOL-DIS to measure quality of life in persons with physical disabilities caused by neurodegenerative disorders. Neurodegener Dis. 2011, vol. 8, no. 4, p. 178-86. doi: 10.1159/000321582. Go to original source... Go to PubMed...
    30. LUENGO-FERNANDEZ, R., LEAL, J. & GRAY, A. et al. Economic burden of cancer across the European Union:a population-based cost analysis. Lancet oncol. 2013,14,1165-74. Go to original source... Go to PubMed...
    31. MARTINÉZ-MARTIN, P., STOCCHII, F. & REICHMAN, H. Quality of Life in Parkinson's Disease-Patient. European Neurological Review. 2014, vol. 9, no. 1,12-8. doi. org/10.17925/ENR.2014.09.01.12. Go to original source...
    32. MELUŠ, V., POLIAKOVÁ, N., BIELIK, J. a LIPOVSKÁ, S. Kvalita života pacientov s Parkinsonovou chorobou na Slovensku. In: Neurologia pre prax. 2019, vol. 20, no. 3. Go to original source...
    33. NAVARRO - PETERNELLA, M. F. & MARCON, S. S. Quality of life a person with Parkinson´s disease and the relationship between the time of evolution and the severity of the disease. Rev Latino-Am Enfermagen. 2012, vol. 20, no. 2. Ribeirão Preto May/ Apr.2012. ISSN 1518-8345. http:// dx.doi.org/10.1590/SO104-11692012000200023. Go to original source... Go to PubMed...
    34. OLESEN, J., GUSTAVSSON, A., SVENSSON, M., WITTCHEN, H. U. & JÖNSSON, B. CDBE2010 STUDY GROUP. EUROPEAN BRAIN COUNCIL. The economic cost of brain disorders in Europe. Eur J Neurol. 2012, Jan, vol. 19, no. 1, p. 155-62. doi: 10.1111/j.1468- 1331.2011.03590.x. PMID: 22175760. Go to original source... Go to PubMed...
    35. OPHEY, A., EGGERS, C., DANO, R., TIMMERMANN, L. & KALBE, E. Health-related quality of life subdomains in patients with Parkinson's disease: the role of gender. Parkinsons Dis. 2018, 9:6532320. doi: 10.1155/2018/6532320. Go to original source... Go to PubMed...
    36. PAUL, B. S., SINGH, G., BANSAL, N., SINGH, G. & PAUL, G. Gender Differences in Impulse Control Disorders and Related Behaviors in Patients with Parkinson's Disease and its Impact on Quality of Life. Ann Indian Acad Neurol. 2020, Sep-Oct, vol. 23, no. 5, p. 632-637. doi: 10.4103/aian.AIAN_47_20. Epub 2020 Dec 8. PMID: 33623263; PMCID: PMC7887492. Go to original source... Go to PubMed...
    37. PHONGPREECHA, T., CHOLERTON, B., MATA, I. F., ZABETIAN, C.P., POSTON, K. L., AGHAEEPOUR, N., TIAN, L., QUINN, J. F., CHUNG, K. A., HILLER, A. L., HU, S. CH., EDWARDS, K. L. & MONTINE, T. J. Multivariate prediction of dementia in Parkinson´s disease. NPJ Parkinsons Dis. 2020, 6:20. https://doi.org/10.1038/s41531-020-00121-2. Go to original source... Go to PubMed...
    38. RAHMAN, S., GRIFFIN, H. J., QUINN, N. P. & JAHANSHAHI, M. Quality of life in Parkinson's disease: the relative importance of the symptoms. Mov Disord. 2008, Jul 30, vol. 23, no. 10, p. 1428-34. doi: 10.1002/mds.21667. PMID: 18543333. Go to original source... Go to PubMed...
    39. RIHMER, Z., SEREGI, K. & RIHMER, A. Parkinson's disease and depression. Neuro- psychopharmacologia Hungarica, 2004, 6, 82-85. PMID: 15787206.
    40. SANTOS-GARCÍA, D. & DE LA FUENTE-FERNÁNDEZ, R. Factors contributing to caregivers' stress and burden in Parkinson's disease. Acta Neurol Scand. 2015, Apr, vol. 131, no. 4, 203-10. doi: 10.1111/ane.12305. Go to original source... Go to PubMed...
    41. SHIN, C., LIM, Y., LIM, H. & AHN, T.B. Plasma Short-Chain Fatty Acids in Patients With Parkinson's Disease. Mov Disord. 2020, Jun, vol. 35, no. 6, p. 1021-1027. doi: 10.1002/ mds.28016. Epub 2020 Mar 10. PMID: 32154946. Go to original source... Go to PubMed...
    42. SIMON-GOZALBO, A., RODRIGUEZ-BLAZQUEZ, C., FORJAZ, M. J. & MARTINEZ-MARTIN, P. Clinical Characterization of Parkinson's Disease Patients With Cognitive Impairment. Front Neurol. 2020, Aug, 4,11:731. doi: 10.3389/fneur.2020.00731. PMID: 32849203; PMCID: PMC7417300. Go to original source... Go to PubMed...
    43. SOH, S. E., MORRIS, M. E., & MCGINLEY, J. L. Determinants of health--related quality of life in Parkinson's disease: a systematic review. Parkinsonism Relat Disord. 2011, vol. 17, no. 1, p. 1-9. Go to original source... Go to PubMed...
    44. SOUZA, R. G., BORGES, V., SILVA, S. M. C. A. & FERRAZ, H.B. Quality of life scale in Parkinson's disease: PDQ-39 (Brazilian Portuguese version) to assess patients with and without levodopa motor fluctuation. Arquivos de Neuro- Psiquiatr. 2007, vol. 65, no. 3-B, p. 787-91. doi.org/10.1590/S0004-282X2007000500010. Go to original source...
    45. SKORVANEK, M., ROSENBERGER, J., MINAR, M., GROFIK, M., HAN, V., GROOTHOFF, J. W., PETER VALKOVIC, P., GDOVINOVA, Z. & van DIJK, J. P. Relationship between the non-motor items of the MDS-UPDRS and Quality of Life in patients with Parkinson's disease. J Neurol Sci. 2015, 353, 1-2, p. 87-91. doi:10.1016/j.jns.2015.04.013. Go to original source... Go to PubMed...
    46. SUN, B. H., WANG, T., LI, N. Y., WU, Q. & QIAO, J. Clinical features and relative factors of constipation in a cohort of Chinese patients with Parkinson's disease. World J Gastrointest Pharmacol Ther. 2021, Jan 5, vol. 12, no. 1, p. 21-31. doi: 10.4292/wjgpt. v12.i1.21. PMID: 33564494; PMCID: PMC7844575. Go to original source... Go to PubMed...
    47. van UEM, J. M. T., CERFF, B., KAMPMEYER, M., PRINZEN, J., ZUIDEMA, M. & HOBERT, M. A. et al. The association between objectively measured physical activity, depression, cognition, and health-related quality of life in Parkinson's disease. Parkinsonism Relat. Disord. 2018, 48, 74-81. doi: 10.1016/j.parkreldis.2017.12.023. Go to original source... Go to PubMed...
    48. VASCONCELLOS, L. F. R., PEREIRA, J. S., CHARCHAT-FICHMAN, H., GRECA, D., CRUZ, M. & BLUM, A. L. et al. Mild cognitive impairment in Parkinson's disease: characterization and impact on quality of life according to subtype. Geriatr. Gerontol. Int. 2019, 19, 497- 502. doi: 10.1111/ggi.13649. Go to original source... Go to PubMed...
    49. VAŠTÍK, M. Centrálne koreláty porúch chôdze u pacientov s Parkinsonovou chorobou. Dizertačná práca. Olomouc: Lekárska fakulta Univerzity Palackého v Olomouci: 2017, 221 s. Dostupné na: https://theses.cz/id/6u4h3x/22480864.
    50. von CAMPENHAUSEN, S., WINTER, Y., RODRIGUES, E. SILVA, A., SAMPAIO, C., RUZICKA, E., BARONE, P., POEWE, W., GUEKHT, A., MATEUS, C., PFEIFFER, K. P., BERGER, K., SKOUPA, J., BÖTZEL, K., GEIGER-GRITSCH, S., SIEBERT, U., BALZER-GELDSETZER, M., OERTEL, W. H., DODEL, R. & REESE, J. P. Costs of illness and care in Parkinson's disease: an evaluation in six countries. Eur Neuropsychopharmacol. 2011, Feb, vol. 21, no. 2, p. 180-91. doi: 10.1016/j.euroneuro.2010.08.002. PMID: 20888737. Go to original source... Go to PubMed...
    51. WINTER, Y., von CAMPENHAUSEN, S., AREND, M., LONGO, K., BOETZEL, K. & EGGERT, K. et al. Health-related quality of life and its determinants in Parkinson's disease: results of an Italian cohort study. Parkinsonism Relat. Disord. 2011, 17, 265-269. doi: 10.1016/j. parkreldis.2011.01.003. Go to original source... Go to PubMed...
    52. WU, Y., GUO, X. Y., WEI, Q. Q., SONG, W., CHEN, K. & CAO, B. et al. Determinants of the quality of life in Parkinson's disease: results of a cohort study from Southwest China. J. Neurol. Sci. 2014, 340, 144-149. doi: 10.1016/j.jns.2014.03.014. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content